Relay Therapeutics, Inc. (RLAY) Free cash flow 2019–2025
Relay Therapeutics, Inc. (RLAY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$235.9MFY2025 · since FY2019: -$74.1M → -$235.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$235.9M | +6.1% |
| FY2024 | -$251.1M | +17.5% |
| FY2023 | -$304.4M | -27.6% |
| FY2022 | -$238.6M | -206.3% |
| FY2021 | -$77.9M | +25.4% |
| FY2020 | -$104.4M | -40.9% |
| FY2019 | -$74.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RLAY financial trends
RLAY RevenueRLAY Net incomeRLAY Net marginRLAY Gross profitRLAY Gross marginRLAY Operating incomeRLAY Operating marginRLAY Operating cash flowRLAY Capital expendituresRLAY Return on equityRLAY Stock buybacksRLAY Dividends paidRLAY Total assetsRLAY Total liabilitiesRLAY Shareholders’ equityRLAY overview →